$CNS Pharmaceuticals (CNSP.US)$ “Key financial metrics from ...

Lnova wrote a post · Nov 15, 2024 17:48

“Key financial metrics from the report indicate that CNS Pharmaceuticals significantly increased its cash and cash equivalents to over $6.9 million from $548,721 at the end of 2023.”

CNS Pharmaceuticals | 10-Q: Quarterly report

*nfa

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

6212 Views

Comment

Lnova

Idealist champion ｡* ҉* ੈ‧₊ ｡ﾟnot financial advice

340

Followers

Following

2924

Visitors